Abstract & Article Details
Short Communication • Vol.1, Issue 5 • ISSN: 2766-2276 • Open Access • CC BY 4.0
Treatment of People with Evans Syndrome in the Setting of COVID-19 Pandemic
Abstract
A new type of pneumonia had developed from Wuhan Province in China in December 2019, caused by a novel member of the Coronaviridae family named Severe Acute Respiratory Coronavirus 2 Syndrome (SARS-CoV-2) [1]. The disease is characterized by fatigue, dry cough, fever, and dyspnea [2]. In a more severe case, the picture may become more complicated by the onset of interstitial pneumonia with alveolar damage, which clinically can lead to severe Acute Respiratory Distress Syndrome (ARDS) and even death [3]. Since the initial outbreak, the epidemic has had a rapid global spread worldwide, which led the World Health Organization (WHO) to declare the disease now called COVID-19, a pandemic on 11th March 2020 [4].
Research Topics
How to Cite
Article Information
| Journal | Journal of Biomedical Research & Environmental Sciences (JBRES) |
|---|---|
| ISSN | 2766-2276 |
| DOI | DOI 10.37871/jbres1137 |
| Volume / Issue | Vol. 1, Issue 5 |
| Received | August 21, 2020 |
| Accepted | September 16, 2020 |
| Published | September 18, 2020 |
| Article Type | Short Communication |
| Pages | 160-162 |
| License | CC BY 4.0 — Open Access |
| Publisher | SciRes Literature LLC, Sheridan, WY, USA |
| Language | English |
Published under CC BY 4.0 — free to share, copy, adapt, and redistribute with attribution.
Certificate of Publication
Certificate verifies that this article was peer-reviewed and published in the Journal of Biomedical Research & Environmental Sciences.